The Effect of Low-Intensity Blood Flow Restriction Therapy on the Management of Acute Ankle Sprains
- Conditions
- Ankle Sprain 2Nd DegreeMusculoskeletal InjuryAnkle Sprain 1St Degree
- Interventions
- Other: Standard Physical TherapyOther: Blood Flow Restriction Therapy
- Registration Number
- NCT05596162
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
The primary objective of this study is to evaluate the feasibility of implementing BFR in the rehabilitation treatment of isolated ankle sprains as well as to evaluate the clinical benefits of BFR when compared to standard treatment. This study will evaluate the efficacy of using BFR therapy for the treatment of acute grade I and II ankle sprains. The investigators will evaluate clinical outcomes of range of motion (ROM) and strength testing of ankle dorsiflexion, plantarflexion, inversion, and eversion.
This will be a small, randomized control trial study. The investigators will enroll a total of 40 participants, 20 participants will undergo standard physical therapy for isolated lateral ankle sprains and 20 participants will undergo BFR therapy for an isolated lateral ankle sprain. Patients will be randomized into control and experimental group via block randomization.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 40
- Patients will include English speaking student athletes aged 18 and older with clinical diagnosis of an isolated grade I or II lateral ankle sprain
- History of DVT/PE, clotting disordered, peripheral arterial disease, hypertension (BP>140/90), coronary artery disease, or pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Non-Blood Flow Restriction Group Standard Physical Therapy This group will perform the same exercises for the same volume without the use of BFR. Blood Flow Restriction Group Blood Flow Restriction Therapy 1. Patient specific tourniquet settings to achieve 80% occlusion. 2. Weight- 20% of 1 rep max, 4 sets 30-15-15-15 reps with 30 second rests between sets 3. Exercises: The first phase will focus on active and passive range of motion of the ankle as well as non-weighted concentric exercises. Phase two will progress with gastrocnemius and soleus stretches along with body weight and light resistance band concentric and eccentric exercises focusing on posterior, anterior and lateral muscle groups of the lower limb. Phase three will introduce weighted, dynamic and proprioceptive exercises.
- Primary Outcome Measures
Name Time Method Time to Return to Play From Time of Injury to 8 weeks after Injury Time from injury to to when injured ankle regains 90% plantarflexion strength compared to uninjured/contralateral side, using a dynamometer.
- Secondary Outcome Measures
Name Time Method The Foot and Ankle Ability Measure (FAAM) Patient-Reported Score Initial visit & 1, 2, 4, and 8 weeks after the initial visit The Foot and Ankle Ability Measure (FAAM) will be used to measure self-reported physical function. It will be measured from 0 to 116 with higher scores meaning a better outcome.
Range of Motion Initial visit & 1, 2, 4, and 8 weeks after the initial visit Range of motion of ankle dorsiflexion, plantarflexion, inversion, and eversion. It will be measured from 0 to 360 with higher scores meaning a worse outcome.
Pain Level Initial visit & 1, 2, 4, and 8 weeks after the initial visit Pain will be assessed with the Visual Analog Pain Scale (VAS). The minimum and maximum scores are 0 and 10 respectively with higher scores meaning a worse outcome.
Strength Testing Initial visit & 1, 2, 4, and 8 weeks after the initial visit Strength testing of ankle dorsiflexion, plantarflexion, inversion, and eversion. It will be measured from 0 to 5 with higher scores meaning a better outcome.
Foot and Ankle Outcome Score (FAOS) Patient-Reported Score Initial visit & 1, 2, 4, and 8 weeks after the initial visit The Foot and Ankle Outcome Score (FAOS) will be used to measure self-reported physical function. It will be measured from 0 to 100% with higher scores meaning a better outcome.
Trial Locations
- Locations (1)
VUMC
🇺🇸Nashville, Tennessee, United States